Biogen Inc (BIIB)
202.49
+0.50
(+0.25%)
USD |
NASDAQ |
Apr 25, 16:00
198.46
-4.03
(-1.99%)
After-Hours: 20:00
Biogen Price: 202.49 for April 25, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 24, 2024 | 198.97 | 205.75 | 198.97 | 201.99 | 3.242M |
| Apr 23, 2024 | 193.34 | 195.86 | 192.75 | 193.18 | 1.462M |
| Apr 22, 2024 | 196.19 | 196.78 | 193.23 | 194.11 | 1.120M |
| Apr 19, 2024 | 190.72 | 194.52 | 189.44 | 194.38 | 1.600M |
| Apr 18, 2024 | 191.75 | 192.56 | 189.52 | 190.52 | 1.512M |
| Apr 17, 2024 | 196.36 | 196.36 | 192.01 | 192.16 | 1.321M |
| Apr 16, 2024 | 196.20 | 197.73 | 194.94 | 195.15 | 872004.0 |
| Apr 15, 2024 | 198.73 | 199.53 | 196.40 | 196.80 | 1.159M |
| Apr 12, 2024 | 204.23 | 205.24 | 197.78 | 198.18 | 1.246M |
| Apr 11, 2024 | 202.76 | 204.74 | 200.92 | 203.68 | 1.019M |
| Apr 10, 2024 | 203.00 | 203.98 | 200.65 | 201.55 | 901006.0 |
| Apr 09, 2024 | 205.02 | 209.06 | 205.02 | 206.52 | 969233.0 |
| Apr 08, 2024 | 203.89 | 205.77 | 202.91 | 204.95 | 723711.0 |
| Apr 05, 2024 | 204.28 | 205.18 | 202.18 | 203.87 | 954570.0 |
| Apr 04, 2024 | 207.24 | 210.00 | 205.22 | 205.30 | 776444.0 |
| Apr 03, 2024 | 207.71 | 208.70 | 205.36 | 206.38 | 904625.0 |
| Apr 02, 2024 | 213.09 | 213.44 | 207.58 | 207.64 | 1.463M |
| Apr 01, 2024 | 215.69 | 215.69 | 212.56 | 214.83 | 850408.0 |
| Mar 28, 2024 | 217.36 | 217.57 | 214.00 | 215.63 | 1.912M |
| Mar 27, 2024 | 213.75 | 216.34 | 212.92 | 216.34 | 1.250M |
| Mar 26, 2024 | 216.15 | 216.67 | 211.02 | 212.02 | 1.590M |
| Mar 25, 2024 | 217.77 | 218.26 | 215.59 | 216.69 | 725946.0 |
| Mar 22, 2024 | 221.30 | 221.30 | 215.36 | 218.10 | 1.071M |
| Mar 21, 2024 | 219.33 | 221.74 | 217.95 | 220.75 | 1.001M |
| Mar 20, 2024 | 217.18 | 219.36 | 216.53 | 218.15 | 945041.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
187.54
Minimum
May 09 2022
414.71
Maximum
Jun 10 2021
263.51
Average
267.21
Median
Mar 23 2021
Price Benchmarks
| Eli Lilly and Co | 724.99 |
| Bristol-Myers Squibb Co | 44.69 |
| Gilead Sciences Inc | 65.28 |
| AbbVie Inc | 167.25 |
| Regeneron Pharmaceuticals Inc | 890.86 |
Price Related Metrics
| PE Ratio | 25.37 |
| PS Ratio | 2.992 |
| Price to Book Value | 1.989 |
| Price to Free Cash Flow | 23.82 |
| Earnings Yield | 3.94% |
| Market Cap | 29.43B |
| Operating PE Ratio | 16.07 |
| Normalized PE Ratio | 18.20 |